Saeed Fatenejad

3PUBLICATIONS

10CO-AUTHORS

Optical technologyAutoimmunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 02, 2024

Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment.

Eugen Feist, Roy M Fleischmann, Saeed Fatenejad

|Sep 15, 2022

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study.

Eugen Feist, Saeed Fatenejad, Sergey Grishin

|Aug 04, 2021

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study.

Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist

Pageof 1

Frequent Collaborators

3 joint publications

Evgeniy Nasonov

2 joint publications

Eugen Feist

2 joint publications

Elena Korneva

2 joint publications

Roy M Fleischmann

1 joint publications

Mariana Ivanova

1 joint publications

Diana G Krechikova

1 joint publications

Aleksey L Maslyanskiy

1 joint publications

Rumen Stoilov

1 joint publications

Mark Genovese

1 joint publications

Sofia Kuzkina

Frequent Collaborators

3 joint publications

Evgeniy Nasonov

2 joint publications

Eugen Feist

2 joint publications

Elena Korneva

2 joint publications

Roy M Fleischmann